Stimulation-specific contribution of p38 and JNK to IFN-β gene expression in human macrophages

Journal of Interferon and Cytokine Research

Volumn 27, Issue 9, 2007, Pages 751-755

  Reimer, Thornik ^a   Schweizer, Matthias ^a   Jungi, Thomas W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BETA INTERFERON; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 3; LIPOPOLYSACCHARIDE; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TANK BINDING KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SENDAI VIRUS; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS;

GENE EXPRESSION; HUMANS; INTERFERON INDUCERS; INTERFERON TYPE II; INTERFERON-BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLY I-C; RNA, MESSENGER; SENDAI VIRUS; VESICULAR STOMATITIS INDIANA VIRUS;

SENDAI VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 34748911452     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0024     Document Type: Article

References (23)

1. Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, Parekh BS, Wathelet MG. Structure and function of the interferon enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 1998;63:609-620.
2. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000;13:539-548.
3. McWhirter SM, Fitzgerald KA, Rosains JR, Daniel C, Golenbock DT, Maniatis T. IFN regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. SCi. USA 2004;101:233-238.
4. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003;4:491-496.
5. Schafer SL, Lin R, Moore PA, Hiscott J, Pitha, PM. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 1998;273:2714-2720.
6. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003;300:1148-1151.
7. Honda K, Taniguchi T. IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 2006;6:644-658.
8. Honda K, Takaoka A, Taniguchi T. Type I inteferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006;25:349-360.
9. Peters KL, Smith HL, Stark GR, Sen GC. IRF-3-dependent, NF-κB- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc. Natl. Acad. Sci. USA 2002;99:6322-6327.
10. Mestas J, Hughes CCW. Of mice and not men: differences between mouse and human immunology. J. Immunol. 2004;172:2731-2738.
11. Panne D, Maniatis T, Harrison SC. Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J. 2004;23:4384-4393.
12. Morton S, Davis RJ, Cohen P. Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2. FEBS Lett. 2004;572:177-183.
13. Bogoyevitch MA, Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol. Mol. Biol. Rev. 2006;70:1061-1095.
14. Jaeschke A, Karasarides M, Ventura J, Jose E, Anka Z, Chao F, Richard A, Shokat KM, Davis RJ. JNK2 is a positive regulator of the cJun transcription factor. Mol. Cell 2006;23:899-911.
15. Navarro L, David M. p38-Dependent activation of interferon regulatory factor 3 by lipopolysaccharide. J. Biol. Chem. 1999;274:35535-35538.
16. Dang O, Navarro L, Anderson K, David M. Cutting edge: anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide. J. Immunol. 2004;172:747-751.
17. Chiang E, Dang O, Anderson K, Matsuzawa A, Ichijo H, David M. Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor-3 by lipopolysaccharide. J. Immunol. 2006;176:5720-5724.
18. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 2001;98:13681-13686.
19. Katsoulidis E, Li Y, Mears H, Platanias LC. The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J. Interferon Cytokine Res. 2005;25:749-756.
20. Han J, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity. Nat. Immunol. 2005;6:1198-1205.
21. Olson CM, Hedrick MN, Izadi H, Bates TC, Olivera ER, Anguita J. p38 Mitogen-activated protein kinase controls NF-κB transcriptional activation and tumor necrosis factor alpha production through Re1A phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens. Inject. Immun. 2007;75:270-277.
22. Li Y, Batra S, Sassano A, Majchrzak B, Levy DE, Gaestel M, Fish EN, Davis RJ, Platanias LC. Activation of mitogen-activated protein kinase kinase (MKK) 3 and MKK6 by type I interferons. J. Biol. Chem. 2005;280:10001-10010.
23. Platanias LC. Mechanisms of type I and type II interferon-mediated signalling. Nat. Rev. Immunol. 2005;5:375-386.